Is anyone using Biktarvy in their dialysis pts? I'm considering it...
In Gilead study GS-US-292-1825, Genvoya remained effective through 96 wks in 55 virologically-suppressed adults on HD for ESRD. FTC exposure was significantly higher than in pts with normal renal function.
Efficacy was also maintained in 10 pts who switched to Biktarvy for 48 wks in the extension phase of the study. Higher FTC and tenofovir concentrations and lower BIC trough were observed (compared to pts with normal renal function) but BIC trough still 4-7x higher than effective concentration. No adverse reactions leading to stopping Biktarvy.
Tenofovir and FTC are eliminated by renal excretion. BIC is eliminated by hepatic metabolism (~1% renal).
Eron JJ, et al. A daily single tablet regimen (STR) of bictegravir/emtricitabine/ tenofovir alafenamide (B/F/TAF) in virologically-suppressed adults living with HIV and end stage renal disease on chronic hemodialysis. IDWeek 2020, October 22-25, 2020. Abstract 1002.
Eron JJ, et al. Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. Lancet HIV. 2018 Dec 13;S2352-3018(18)30296-0.
------------------------------
Elliot Goodenough
Philadelphia PA
------------------------------
Original Message:
Sent: 04-09-2020 01:15
From: Dena Dillon
Subject: ART Choice with Chronic Kidney Disease
I've recommended Triumeq (dolutegravir/abacavir/lamivudine) for some of my patients with hemodialysis. There's a relatively small study which found it was tolerated and effective for people with ESRD on HD.
Dena Dillon, Pharm.D., AAHIVP
Notice: This UI Health Care e-mail (including attachments) is covered by the Electronic Communications Privacy Act, 18 U.S.C. 2510-2521 and is intended only for the use of the individual or entity to which it is addressed, and may contain information that is privileged, confidential, and exempt from disclosure under applicable law. If you are not the intended recipient, any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately and delete or destroy all copies of the original message and attachments thereto. Email sent to or from UI Health Care may be retained as required by law or regulation. Thank you.
Original Message------
What regimen(s) do use in selecting ART for your patients with CKD?
i have some patients (HLAB5701 negative) on DTG ABC and renaly adjusted 3TC. Do you still adjust the 3TC dose? Anyone ever use TAF in a CKD patient? While Descovy approved down to EGFR 30, Vemlidy for HBV is Approved down to EGFR 15. Interested to hear your thoughts. I have a dialysis patient on Juluca, but RPV not for everyone.
Gary
------------------------------
Gary F. Spinner PA,MPH,AAHIVS
Southwest Community Health Center
Bridgeport, CT
gspinner@swchc.org
Gary.spinner@aya.yale.edu
------------------------------